• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual.

作者信息

Vickers Selwyn M, Fouad Mona N

机构信息

Department of Surgery, University of Minnesota, Minneapolis, Minnesota.

出版信息

Cancer. 2014 Apr 1;120 Suppl 7(0 7):1087-90. doi: 10.1002/cncr.28569.

DOI:10.1002/cncr.28569
PMID:24643645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4133979/
Abstract
摘要

相似文献

1
An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual.增强少数群体参与癌症临床试验（EMPaCT）概述及影响少数群体参与癌症临床试验的基本问题：增强少数群体参与临床试验（EMPaCT）：为改善少数群体临床试验入组奠定基础。
Cancer. 2014 Apr 1;120 Suppl 7(0 7):1087-90. doi: 10.1002/cncr.28569.
2
Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.NIH 复兴法案颁布 20 年后：增强少数族裔参与临床试验（EMPaCT）：为改善少数族裔临床试验入组奠定基础：重申增强少数族裔参与癌症临床试验的必要性。
Cancer. 2014 Apr 1;120 Suppl 7(0 7):1091-6. doi: 10.1002/cncr.28575.
3
Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT).癌症中心领导者、研究人员、研究人员和转诊临床医生对临床试验中少数民族招募的障碍和促进因素的看法：增强少数民族参与临床试验（EMPaCT）。
Cancer. 2014 Apr 1;120 Suppl 7(0 7):1097-105. doi: 10.1002/cncr.28574.
4
Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.五个美国国家癌症研究所指定癌症中心关于少数民族参与治疗性试验的数据收集：现状和改进机会。
Cancer. 2014 Apr 1;120 Suppl 7(0 7):1113-21. doi: 10.1002/cncr.28571.
5
State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual.患者导航作为一种增强少数民族参与临床试验策略的科学现状。
Cancer. 2014 Apr 1;120 Suppl 7(0 7):1122-30. doi: 10.1002/cncr.28570.
6
An institutional strategy to increase minority recruitment to therapeutic trials.一项增加少数民族参与治疗性试验的机构策略。
Cancer Causes Control. 2013 Oct;24(10):1797-809. doi: 10.1007/s10552-013-0258-1. Epub 2013 Jul 12.
7
Racial and ethnic health disparities in healthcare settings.医疗环境中的种族和民族健康差异。
BMJ. 2021 Mar 8;372:n605. doi: 10.1136/bmj.n605.
8
Increasing Diversity in Clinical Trials: Overcoming Critical Barriers.提高临床试验的多样性：克服关键障碍。
Curr Probl Cardiol. 2019 May;44(5):148-172. doi: 10.1016/j.cpcardiol.2018.11.002. Epub 2018 Nov 9.
9
Psychopharmacological research ethics: special issues affecting US ethnic minorities.精神药理学研究伦理：影响美国少数族裔的特殊问题。
Psychopharmacology (Berl). 2003 Dec;171(1):98-104. doi: 10.1007/s00213-003-1630-8. Epub 2003 Nov 18.
10
Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all.癌症临床试验入组：解决差异方面错失的机会以及改善所有人治疗结果方面错失的机会。
Ann Surg Oncol. 2008 Jul;15(7):1818-9. doi: 10.1245/s10434-008-9869-2. Epub 2008 Apr 19.

引用本文的文献

1
Gender, race, and ethnicity in lung cancer clinical trial participation: Analysis of 253,845 patients from 2002 to 2021.肺癌临床试验参与中的性别、种族和民族：对2002年至2021年253,845名患者的分析。
J Thorac Cardiovasc Surg. 2025 May;169(5):1346-1353.e1. doi: 10.1016/j.jtcvs.2024.09.040. Epub 2024 Sep 29.
2
An in-person and technology-implemented holistic health promotion program for older Black adults in low-income communities.面向低收入社区的老年黑人的亲身参与和技术实施的整体健康促进计划。
J Natl Med Assoc. 2024 Feb;116(1):83-92. doi: 10.1016/j.jnma.2023.12.008. Epub 2024 Jan 2.
3
The Impact and Opportunity of Inclusive Excellence: Addressing Social Determinants of Health in Cancer Clinical Trials.包容性卓越的影响与机遇：在癌症临床试验中解决健康的社会决定因素
Ann Surg Oncol. 2023 Dec;30(13):8036-8043. doi: 10.1245/s10434-023-14288-4. Epub 2023 Sep 29.
4
Clinical trial participation among underserved communities: Insights from the Louisiana Community Engagement Alliance.服务不足社区的临床试验参与：来自路易斯安那社区参与联盟的见解。
Am J Med Sci. 2023 Oct;366(4):254-262. doi: 10.1016/j.amjms.2023.07.011. Epub 2023 Jul 28.
5
Implementing barbershop-based health-promotion interventions for Black men: A systematic scoping review.实施以理发店为基础的健康促进干预措施，促进黑人男性健康：系统范围界定综述。
Health Psychol. 2023 Jul;42(7):435-447. doi: 10.1037/hea0001294. Epub 2023 May 25.
6
Trends and Disparities in Clinical Trial Enrollment as Part of First-Line Treatment for Upper Gastrointestinal and Hepatopancreatobiliary Malignancies.作为上消化道及肝胆胰恶性肿瘤一线治疗一部分的临床试验入组情况的趋势与差异
Ann Surg Oncol. 2023 Sep;30(9):5323-5326. doi: 10.1245/s10434-023-13641-x. Epub 2023 May 16.
7
The Landmark Series-Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women.地标系列——解决乳腺癌筛查中的差异：黑种女性的新建议。
Ann Surg Oncol. 2023 Jan;30(1):58-67. doi: 10.1245/s10434-022-12535-8. Epub 2022 Oct 3.
8
Promoting weight-loss maintenance among Black women primary care patients: A cluster RCT of a culturally sensitive versus standard behavioural approach.促进黑人女性初级保健患者的减肥维持：一种文化敏感与标准行为方法的聚类 RCT。
Clin Obes. 2022 Dec;12(6):e12553. doi: 10.1111/cob.12553. Epub 2022 Sep 23.
9
Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.在早期三阴性乳腺癌患者中，度伐利尤单抗联合新辅助化疗的 I/II 期临床试验中按种族划分的临床结局和免疫标志物。
Clin Cancer Res. 2022 Sep 1;28(17):3720-3728. doi: 10.1158/1078-0432.CCR-22-0862.
10
Effectiveness of Recruitment Strategies of Latino Smokers: Secondary Analysis of a Mobile Health Smoking Cessation Randomized Clinical Trial.拉丁裔烟民招募策略的有效性：一项移动健康戒烟随机临床试验的二次分析。
J Med Internet Res. 2022 Jun 27;24(6):e34863. doi: 10.2196/34863.

本文引用的文献

1
Does enrollment in cancer trials improve survival?癌症临床试验的参与是否能改善生存？
J Am Coll Surg. 2013 Apr;216(4):774-80; discussion 780-1. doi: 10.1016/j.jamcollsurg.2012.12.036. Epub 2013 Feb 13.
2
Cancer clinical trials--a chronic but curable crisis.癌症临床试验——一场长期但可治愈的危机。
N Engl J Med. 2010 Jul 22;363(4):306-9. doi: 10.1056/NEJMp1005843. Epub 2010 Jun 16.
3
An examination of community members', researchers' and health professionals' perceptions of barriers to minority participation in medical research: an application of concept mapping.对社区成员、研究人员和卫生专业人员关于少数群体参与医学研究的障碍认知的考察：概念图的应用
Ethn Health. 2007 Nov;12(5):521-39. doi: 10.1080/13557850701616987.
4
Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.参与外科肿瘤学临床试验：基于性别、种族/民族和年龄的差异。
Ann Surg Oncol. 2007 Dec;14(12):3328-34. doi: 10.1245/s10434-007-9500-y. Epub 2007 Aug 8.
5
Predictors of enrollment in lung cancer clinical trials.肺癌临床试验入组的预测因素。
Cancer. 2006 Jan 15;106(2):420-5. doi: 10.1002/cncr.21638.
6
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival.1975 - 2001年美国癌症现状年度报告，附生存情况专题内容
Cancer. 2004 Jul 1;101(1):3-27. doi: 10.1002/cncr.20288.
7
Participation in cancer clinical trials: race-, sex-, and age-based disparities.参与癌症临床试验：基于种族、性别和年龄的差异。
JAMA. 2004 Jun 9;291(22):2720-6. doi: 10.1001/jama.291.22.2720.
8
Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients.非裔美国人和白人心脏病患者对种族主义的态度、对医疗的不信任以及对护理的满意度。
Med Care Res Rev. 2000;57 Suppl 1:146-61. doi: 10.1177/1077558700057001S07.
9
Racial and ethnic differences in access to medical care.获得医疗服务方面的种族和族裔差异。
Med Care Res Rev. 2000;57 Suppl 1:108-45. doi: 10.1177/1077558700057001S06.
10
Barriers to care among racial/ethnic groups under managed care.管理式医疗下种族/族裔群体的就医障碍。
Health Aff (Millwood). 2000 Jul-Aug;19(4):65-75. doi: 10.1377/hlthaff.19.4.65.